CCL1 and breast cancer: In addition, regarding RFS, BC patients with increased mRNA levels of CCL1/3/4/5/11/13/14/15/16/19/21/22/23/25 and CXCL2/3/4/5/6/7/12/14/16 were significantly correlated with favorable RFS (P < 0.05).